X-54923136-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001039705.3(TRO):āc.604C>Gā(p.Pro202Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000413 in 1,209,654 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001039705.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRO | NM_001039705.3 | c.604C>G | p.Pro202Ala | missense_variant | 3/13 | ENST00000173898.12 | NP_001034794.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRO | ENST00000173898.12 | c.604C>G | p.Pro202Ala | missense_variant | 3/13 | 1 | NM_001039705.3 | ENSP00000173898 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000179 AC: 2AN: 111497Hom.: 0 Cov.: 23 AF XY: 0.0000297 AC XY: 1AN XY: 33681
GnomAD4 exome AF: 0.00000273 AC: 3AN: 1098157Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 1AN XY: 363515
GnomAD4 genome AF: 0.0000179 AC: 2AN: 111497Hom.: 0 Cov.: 23 AF XY: 0.0000297 AC XY: 1AN XY: 33681
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2023 | The c.604C>G (p.P202A) alteration is located in exon 3 (coding exon 2) of the TRO gene. This alteration results from a C to G substitution at nucleotide position 604, causing the proline (P) at amino acid position 202 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at